Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6)

被引:186
作者
Iliás, A
Urbán, Z
Seidl, TL
Le Saux, O
Sinkó, E
Boyd, CD
Sarkadi, B
Váradi, A
机构
[1] Hungarian Acad Sci, Inst Enzymol, H-1113 Budapest, Hungary
[2] Univ Hawaii, Pacific Biomed Res Ctr, Lab Matrix Pathobiol, Honolulu, HI 96822 USA
[3] Hungarian Acad Sci, Res Grp, Inst Haematol & Immunol, Natl Med Ctr, H-1113 Budapest, Hungary
关键词
D O I
10.1074/jbc.M110918200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the ABCC6 (MRP6) gene cause pseudoxanthoma elasticum (PXE), a rare heritable disorder resulting in the calcification of elastic fibers. In the present study a cDNA encoding a full-length normal variant of ABCC6 was amplified from a human kidney cDNA library, and the protein was expressed in Sf9 insect cells. In isolated membranes ATP binding as well as ATP-dependent active transport by ABCC6 was demonstrated. We found that glutathione conjugates, including leukotriene C-4 and N-ethylmaleimide S-glutathione (NEM-GS), were actively transported by human ABCC6. Organic anions (probenecid, benzbromarone, indomethacin), known to interfere with glutathione conjugate transport of human ABCC1 and ABCC2, inhibited the ABCC6-mediated NEM-GS transport in a specific manner, indicating that ABCC6 has a unique substrate specificity. We have also expressed three missense mutant forms of ABCC6, which have recently been shown to cause PXE. MgATP binding was normal in these proteins; ATP-dependent NEM-GS or leukotriene C-4 transport, however, was abolished. Our data indicate that human ABCC6 is a primary active transporter for organic anions. In the three ABCC6 mutant forms examined, the loss of transport activity suggests that these mutations result in a PXE phenotype through a direct influence on the transport activity of this ABC transporter.
引用
收藏
页码:16860 / 16867
页数:8
相关论文
共 49 条
[1]   Traffic jam: A compendium of human diseases that affect intracellular transport processes [J].
Aridor, M ;
Hannan, LA .
TRAFFIC, 2000, 1 (11) :836-851
[2]   Membrane topology and glycosylation of the human multidrug resistance-associated protein [J].
Bakos, E ;
Hegedus, T ;
Hollo, Z ;
Welker, E ;
Tusnady, GE ;
Zaman, GJR ;
Flens, MJ ;
Varadi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12322-12326
[3]   Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[4]   Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions [J].
Bakos, É ;
Evers, R ;
Sinkó, E ;
Váradi, A ;
Borst, P ;
Sarkadi, B .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :760-768
[5]   MOAT-E (ARA) is a full-length MRP cMOAT subfamily transporter expressed in kidney and liver [J].
Belinsky, MG ;
Kruh, GD .
BRITISH JOURNAL OF CANCER, 1999, 80 (09) :1342-1349
[6]   Mutations in ABCC6 cause pseudoxanthoma elasticum [J].
Bergen, AAB ;
Plomp, AS ;
Schuurman, EJ ;
Terry, S ;
Breuning, M ;
Dauwerse, H ;
Swart, J ;
Kool, M ;
van Soest, S ;
Baas, F ;
ten Brink, JB ;
de Jong, PTVM .
NATURE GENETICS, 2000, 25 (02) :228-231
[7]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[8]   The multidrug resistance protein family [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1461 (02) :347-357
[9]   ATPase activity of purified multidrug resistance-associated protein [J].
Chang, XB ;
Hou, YX ;
Riordan, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30962-30968
[10]  
Cui YH, 1999, MOL PHARMACOL, V55, P929